netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

AMD Drug Can Prevent Vision Loss in Diabetics With Diabetic Macular Edema

RPB-supported researchers at the University of Southern California (USC) report that ranibizumab (sold as Lucentis) can help Hispanic and non-Hispanic whites with diabetic macular edema (DME) in the United States avoid visual impairment and blindness.  Diabetic retinopathy and DME are the leading causes of vision loss in working-age adults in the United States.

Read the story on the USC's website

Read the research in Ophthalmology

Related News: Top Story

scEYEnce campaign image

RPB and Partners Launch the scEYEnce Campaign

This new media campaign shines a spotlight on the powerful benefits of vision research.

Read More

 
David Williams

RPB and Association of University Professors of Ophthalmology Announce 2021 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

David Williams, PhD, is recognized for ground-breaking contributions to the field of vision research.

Read More

 
Michael Chiang

Former RPB Grantee Dr. Michael Chiang Named Director of National Eye Institute

Dr. Chiang is a respected scientist, clinician and leader in vision research.

Read More

 
RPB logo

Research to Prevent Blindness Expands Career Development Award

RPB is increasing both the amount of funding and the number of awards funded through its flagship grant in order to better support early-career vision scientists.

Read More

 
RPB logo

Research to Prevent Blindness and Allergan Foundation Announce New Partnership to Support Early-Career Vision Researchers

The organizations announce new grants to increase funding for innovative research from early-career vision scientists.

Read More

 
RPB logo
Watch The Video

Research to Prevent Blindness Celebrates 60th Anniversary

For the past 60 years, RPB has funded groundbreaking research to prevent, treat and cure all conditions that damage or destroy sight.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.